Scientists Worry Bush Will Cut Stem Cell Research Funding

Article

WASHINGTON, DC-Newly elected President Bush said Friday he thinks scientists should be using adult stem cells for their research.

The only problem is that most researchers use stem cells derived from aborted fetuses or fertility clinic's discarded embryos. Embryonic stem cells are the best to work with because they are more flexible than adult stem cells.

Researchers are focusing on stem cells because they are the building blocks for all human tissue. Scientists think that stem cell research could lead to revolutionary therapies for many diseases.

Currently, federally funded scientists cannot touch human embryos, but privately funded studies have been multiplying embryotic stem cells for some time. President Bush said he prefers research on adult stem cells.

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Recent Videos
 Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
 Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
In a recent discussion with Infection Control Today® (ICT®), study authors Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio, shared their insights on how the project evolved and what the findings mean for the future.